US2166963A
(en)
*
|
1936-11-19 |
1939-07-25 |
Sharp & Dohme Inc |
Antigenic polysaccharide complex
|
CH417852A
(fr)
*
|
1961-05-15 |
1966-07-31 |
Parke Davis & Co |
Procédé de préparation d'un antigène staphylococcique
|
US3269913A
(en)
*
|
1962-05-11 |
1966-08-30 |
Parke Davis & Co |
Staphylococcal-immunizing products and methods for their production
|
GB995338A
(en)
|
1963-09-20 |
1965-06-16 |
Parke Davis & Co |
Polysaccharides and methods for their production
|
JPS5452794A
(en)
|
1977-09-30 |
1979-04-25 |
Kousaku Yoshida |
Extracting of polysacchride from capusle containing epidermis staphylococus
|
US4663160A
(en)
*
|
1983-03-14 |
1987-05-05 |
Miles Laboratories, Inc. |
Vaccines for gram-negative bacteria
|
US4808700A
(en)
*
|
1984-07-09 |
1989-02-28 |
Praxis Biologics, Inc. |
Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
|
US5055455A
(en)
*
|
1988-09-28 |
1991-10-08 |
Brigham And Women's Hospital |
Capsular polysaccharide adhesin antigen, preparation, purification and use
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
EP0378881B1
(en)
|
1989-01-17 |
1993-06-09 |
ENIRICERCHE S.p.A. |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
AU651949B2
(en)
|
1989-07-14 |
1994-08-11 |
American Cyanamid Company |
Cytokine and hormone carriers for conjugate vaccines
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
IL98715A0
(en)
|
1990-08-13 |
1992-07-15 |
American Cyanamid Co |
Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines
|
US5153312A
(en)
|
1990-09-28 |
1992-10-06 |
American Cyanamid Company |
Oligosaccharide conjugate vaccines
|
FR2682388B1
(fr)
|
1991-10-10 |
1995-06-09 |
Pasteur Merieux Serums Vacc |
Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
|
CA2123811C
(en)
*
|
1991-11-22 |
2005-07-05 |
Ali Ibrahim Fattom |
Type i and type ii surface antigens associated with staphylococcus epidermidis
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
US5679654A
(en)
*
|
1994-09-02 |
1997-10-21 |
Brigham & Women's Hospital, Inc. |
Capsular polysaccharide immunomodulator
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
US6743430B1
(en)
*
|
1995-03-29 |
2004-06-01 |
Richard E. Parizek |
Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
|
BR9608612A
(pt)
|
1995-06-07 |
1999-05-04 |
Smithkline Beecham Biolog |
Vacina compreendendo um conjugado de antígeno de polissacarídeo - proteína portadora e proteína portadora livre
|
US6294177B1
(en)
*
|
1996-09-11 |
2001-09-25 |
Nabi |
Staphylococcus aureus antigen-containing whole cell vaccine
|
US5770208A
(en)
|
1996-09-11 |
1998-06-23 |
Nabi |
Staphylococcus aureus B-linked hexosamine antigen
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
CA2284606A1
(en)
|
1997-03-26 |
1998-10-01 |
Brigham And Women's Hospital, Inc. |
Method for generating saccharide fragments
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
CA2308606A1
(en)
|
1997-11-06 |
1999-05-20 |
Chiron S.P.A. |
Neisserial antigens
|
BR9814878A
(pt)
|
1997-11-21 |
2000-10-03 |
Genset Sa |
Sequência genÈmica e polipeptìdeos de chlamydia pneumoniae, fragmentos dos mesmos e usos dos mesmos, em particular para o diagnóstico, a prevenção e o tratamento de infecção
|
KR100735651B1
(ko)
|
1997-11-28 |
2007-07-06 |
세로노 제네틱스 인스티튜트 에스.에이. |
클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
|
AU1979599A
(en)
|
1998-01-14 |
1999-08-02 |
Chiron S.P.A. |
(neisseria meningitidis) antigens
|
US7018637B2
(en)
|
1998-02-23 |
2006-03-28 |
Aventis Pasteur, Inc |
Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
|
GB9808932D0
(en)
*
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
BR9910089A
(pt)
|
1998-05-01 |
2004-06-08 |
Chiron Corp |
Composições e antìgenos de neisseria meningitidis
|
US7252828B2
(en)
*
|
1998-07-15 |
2007-08-07 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
JP2004511201A
(ja)
|
1998-10-09 |
2004-04-15 |
カイロン コーポレイション |
ナイセリアゲノム配列およびそれらの使用方法
|
WO2000027994A2
(en)
|
1998-11-12 |
2000-05-18 |
The Regents Of The University Of California |
Chlamydia pneumoniae genome sequence
|
GB9828000D0
(en)
|
1998-12-18 |
1999-02-10 |
Chiron Spa |
Antigens
|
US6146902A
(en)
|
1998-12-29 |
2000-11-14 |
Aventis Pasteur, Inc. |
Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
|
CZ303653B6
(cs)
|
1999-03-19 |
2013-01-30 |
Smithkline Beecham Biologicals S. A. |
Imunogenní prostredek
|
US6936258B1
(en)
|
1999-03-19 |
2005-08-30 |
Nabi Biopharmaceuticals |
Staphylococcus antigen and vaccine
|
WO2000061761A2
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
US7534866B2
(en)
|
2005-10-19 |
2009-05-19 |
Ibc Pharmaceuticals, Inc. |
Methods and compositions for generating bioactive assemblies of increased complexity and uses
|
US6689567B1
(en)
*
|
1999-05-28 |
2004-02-10 |
University Of Guelph |
Method for assaying the function of FlaA1 and WbpM
|
PT2289545T
(pt)
|
2000-01-17 |
2016-09-06 |
Glaxosmithkline Biologicals Sa |
Vacina de omv suplementada contra meningococos
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
EP1297005B1
(en)
|
2000-07-03 |
2009-08-26 |
Novartis Vaccines and Diagnostics S.r.l. |
Immunisation against chlamydia pneumoniae
|
MXPA03003690A
(es)
|
2000-10-27 |
2004-05-05 |
Chiron Spa |
Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
|
US20030035806A1
(en)
|
2001-05-11 |
2003-02-20 |
D'ambra Anello J. |
Novel meningitis conjugate vaccine
|
US6537577B1
(en)
*
|
2001-06-04 |
2003-03-25 |
Bio Medical Development Corporation |
Method of prophylaxis for bovine mastitis
|
GB2379996B
(en)
*
|
2001-06-05 |
2004-05-19 |
Tayside Flow Technologies Ltd |
Flow means
|
ATE429484T1
(de)
*
|
2001-06-11 |
2009-05-15 |
Applied Nanosystems Bv |
Verfahren zur bindung von acma-typ protein anker fusionen an mikroorganismen zellwandmaterialien
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
US20040161741A1
(en)
|
2001-06-30 |
2004-08-19 |
Elazar Rabani |
Novel compositions and processes for analyte detection, quantification and amplification
|
US20030113350A1
(en)
*
|
2001-09-19 |
2003-06-19 |
Fattom Ali I. |
Glycoconjugate vaccines for use in immune-compromised populations
|
GB0210128D0
(en)
|
2002-05-02 |
2002-06-12 |
Chiron Spa |
Nucleic acids and proteins from streptococcus groups A & B
|
WO2004011027A1
(en)
|
2002-07-30 |
2004-02-05 |
Baxter International Inc. |
Chimeric multivalent polysaccharide conjugate vaccines
|
US20060121058A1
(en)
*
|
2002-08-08 |
2006-06-08 |
Children's Medical Center Corporation |
Anti-pneumococcal preparations
|
AU2003260102A1
(en)
|
2002-08-26 |
2004-03-11 |
Chiron Corporation |
Conserved and specific streptococcal genomes
|
GB0220198D0
(en)
*
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Modified saccharides,conjugates thereof and their manufacture
|
US20070036828A1
(en)
|
2002-09-13 |
2007-02-15 |
Chiron Corporation |
Group b streptococcus vaccine
|
WO2004043407A2
(en)
|
2002-11-12 |
2004-05-27 |
The Brigham And Women's Hospital, Inc. |
Methods and products for treating staphylococcal infections
|
CA2501077C
(en)
|
2002-11-12 |
2016-06-21 |
Gerald B. Pier |
Polysaccharide vaccine for staphylococcal infections
|
GB0227346D0
(en)
*
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
AU2004220590B2
(en)
|
2003-03-07 |
2010-02-18 |
Inhibitex, Inc. |
Polysaccharide - Staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
|
US8084235B2
(en)
|
2003-03-13 |
2011-12-27 |
Glaxosmithkline Biologicals S.A. |
Purification process for bacterial cytolysin
|
DE602004017864D1
(de)
*
|
2003-06-23 |
2009-01-02 |
Baxter Int |
Trägerproteine für impfstoffe
|
US20060188515A1
(en)
|
2003-07-24 |
2006-08-24 |
Anderson Annaliesa S |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
PT1651166E
(pt)
|
2003-07-24 |
2010-04-23 |
Merck Sharp & Dohme |
Polipeptidos para indução de uma resposta imunitária de protecção contra staphylococcus aureus
|
US8048432B2
(en)
*
|
2003-08-06 |
2011-11-01 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Polysaccharide-protein conjugate vaccines
|
US7582459B2
(en)
*
|
2003-09-11 |
2009-09-01 |
De Staat Der Nederlanden, Vert. Door De Minister Van Vws |
Process for producing a capsular polysaccharide for use in conjugate vaccines
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
CN1918176A
(zh)
|
2004-02-18 |
2007-02-21 |
默克公司 |
用于诱导针对金黄色葡萄球菌的保护性免疫反应的多肽
|
US20070172498A1
(en)
|
2004-02-27 |
2007-07-26 |
Anderson Annaliesa S |
Polypeptides for inducing a protective immune response against staphyloococcus aureus
|
US20050250821A1
(en)
*
|
2004-04-16 |
2005-11-10 |
Vincent Sewalt |
Quaternary ammonium compounds in the treatment of water and as antimicrobial wash
|
WO2006065272A2
(en)
*
|
2004-05-21 |
2006-06-22 |
Idaho Research Foundation, Inc. |
Methods for altering acetic acid production and enhancing cell death in bacteria
|
WO2005115113A2
(en)
|
2004-05-25 |
2005-12-08 |
Merck & Co., Inc. |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
GB0413868D0
(en)
*
|
2004-06-21 |
2004-07-21 |
Chiron Srl |
Dimensional anlaysis of saccharide conjugates
|
EP1791978A4
(en)
|
2004-09-17 |
2008-02-27 |
Merck & Co Inc |
POLYPEPTIDES INDUCING AN IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS AUREUS
|
EP2305294B1
(en)
|
2004-09-22 |
2015-04-01 |
GlaxoSmithKline Biologicals SA |
Immunogenic composition for use in vaccination against staphylococcei
|
US20060134141A1
(en)
|
2004-12-14 |
2006-06-22 |
Nabi Biopharmaceuticals |
Glycoconjugate vaccines containing peptidoglycan
|
AU2006206577B2
(en)
|
2005-01-21 |
2012-03-08 |
Merck Sharp & Dohme Corp. |
Polypeptides for inducing a protective immune response against Staphylococcus aureus
|
GB0502096D0
(en)
*
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Purification of streptococcal capsular polysaccharide
|
US20060228368A1
(en)
|
2005-04-07 |
2006-10-12 |
Nabi Biopharmaceuticals |
Method of protecting against staphylococcal infection
|
FR2884830A1
(fr)
|
2005-04-25 |
2006-10-27 |
Sanofi Pasteur Sa |
Procede de production de souches de staphylococcus aureus surproductrices
|
KR101408113B1
(ko)
*
|
2005-06-27 |
2014-06-16 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
백신 제조 방법
|
WO2007023386A2
(en)
*
|
2005-08-24 |
2007-03-01 |
Novartis Vaccines And Diagnostics Srl |
Zwitterionization of capsular saccharides
|
GB0526038D0
(en)
|
2005-12-21 |
2006-02-01 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
EP1976857A4
(en)
|
2006-01-13 |
2011-08-03 |
Baxter Int |
PROCESS FOR CLEANING POLYSACCHARIDES
|
EP2476434A1
(en)
*
|
2006-03-30 |
2012-07-18 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
AR060188A1
(es)
*
|
2006-03-30 |
2008-05-28 |
Glaxosmithkline Biolog Sa |
Procedimiento de conjugacion
|
FR2899110A1
(fr)
*
|
2006-03-31 |
2007-10-05 |
Sanofi Pasteur Sa |
Polysaccharides capsulaires de type 5 et de type 8 des souches surproductrices de staphylococcus aureus
|
NZ574057A
(en)
|
2006-06-12 |
2012-01-12 |
Glaxosmithkline Biolog Sa |
Staphylococcal antigen composition comprising an isolated S. aureus type 5 antigen; an isolated S. aureus type 8 antigen; an isolated S. aureus 336 antigen; an isolated S. aureus alpha-toxin antigen; and an isolated Staphylococcal leukocidin antigen
|
GB0612854D0
(en)
*
|
2006-06-28 |
2006-08-09 |
Novartis Ag |
Saccharide analysis
|
CA2667788A1
(en)
|
2006-10-30 |
2008-12-18 |
The University Of Western Ontario |
Staphylococcus aureus specific anti-infectives
|
EP2094317B1
(en)
*
|
2006-11-08 |
2010-09-15 |
B-K Medical ApS |
Method for multi-step sterilization
|
DE102006062398A1
(de)
|
2006-12-20 |
2008-06-26 |
Edi (Experimentelle & Diagnostische Immunologie) Gmbh |
Verfahren zur Erkennung und/oder Charakterisierung zellulärer Aktivitätsmuster, Verwendung von Toll-like-Rezeptor-Liganden (TLR-Liganden) und ein Kit
|
GB0700136D0
(en)
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Process for manufacturing vaccines
|
GB0700135D0
(en)
*
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Vaccine
|
CN101679516B
(zh)
|
2007-05-31 |
2013-11-13 |
默沙东公司 |
靶向金黄色葡萄球菌ORF0657n的抗原结合蛋白
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
CA2697538C
(en)
|
2007-08-31 |
2019-02-12 |
University Of Chicago |
Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
|
EP2254592B1
(en)
|
2008-02-28 |
2019-06-05 |
Dako Denmark A/S |
Mhc multimers in borrelia diagnostics and disease
|
CN102356090B
(zh)
*
|
2008-09-17 |
2016-01-20 |
诺华股份有限公司 |
组合gas疫苗和治疗方法
|
WO2010042481A1
(en)
*
|
2008-10-06 |
2010-04-15 |
University Of Chicago |
Compositions and methods related to bacterial eap, emp, and/or adsa proteins
|
WO2010132833A1
(en)
*
|
2009-05-14 |
2010-11-18 |
The Regents Of The University Of Michigan |
Streptococcus vaccine compositions and methods of using the same
|
WO2010151544A1
(en)
|
2009-06-22 |
2010-12-29 |
Wyeth Llc |
Immunogenic compositions of staphylococcus aureus antigens
|
JP2012530785A
(ja)
*
|
2009-06-22 |
2012-12-06 |
ワイス・エルエルシー |
組成物および黄色ブドウ球菌(Staphylococcusaureus)血清型5および8莢膜多糖コンジュゲート免疫原性組成物を調製するための方法
|
GB0913681D0
(en)
*
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
CA2779798C
(en)
*
|
2009-09-30 |
2019-03-19 |
Novartis Ag |
Conjugation of staphylococcus aureus type 5 and type 8 capsular polysaccharides
|
JP5914344B2
(ja)
*
|
2009-10-30 |
2016-05-11 |
ノバルティス アーゲー |
Staphylococcusaureus5型および8型の莢膜糖の精製
|
WO2011081075A1
(ja)
*
|
2009-12-28 |
2011-07-07 |
キッコーマン株式会社 |
黄色ブドウ球菌抗原の抽出方法、黄色ブドウ球菌抗原の抽出用試薬および黄色ブドウ球菌の判定方法
|
WO2011080595A2
(en)
|
2009-12-30 |
2011-07-07 |
Novartis Ag |
Polysaccharide immunogens conjugated to e. coli carrier proteins
|
AU2011274367B2
(en)
*
|
2010-07-02 |
2015-04-23 |
The University Of Chicago |
Compositions and methods related to protein A (SpA) variants
|
GB201310008D0
(en)
*
|
2013-06-05 |
2013-07-17 |
Glaxosmithkline Biolog Sa |
Immunogenic composition for use in therapy
|
CA2932225C
(en)
|
2013-12-04 |
2023-01-17 |
Glycovaxyn Ag |
Prevention of staphylococcus aureus infections by glycoprotein vaccines synthesized in escherichia coli
|
US9775872B2
(en)
|
2014-08-20 |
2017-10-03 |
Professional Compounding Centers Of America |
Topical pharmaceutical bases for preventing viral diseases
|
WO2018217564A1
(en)
*
|
2017-05-22 |
2018-11-29 |
The Children's Medical Center Corporation |
Combined vaccine against mycobacterium tuberculosis
|